(Total Views: 117)
Posted On: 11/23/2023 1:28:49 AM
Post# of 35
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Japan’s Pharmaceuticals and Medical Devices Agency (“PMDA”) has accepted Alpha Tau’s submission requesting shonin pre-market approval of Alpha DaRT in patients with recurrent head & neck cancer
https://www.alphatau.com/single-post/atm-subm...eck-cancer
https://www.alphatau.com/single-post/atm-subm...eck-cancer
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)